Drug Pipeline

Lacosamide Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
1
Phase 3
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-04 NCT05603702
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With…		 overall status: "Recruiting" → "Active Not Recruiting"
2026-06-04 NCT05603702
STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With…		 Enrollment reduced: 24 -> 21 participants
Active Studies by Phase
Phase 4
1
Phase 3
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06866691 Seizure Prevention in Traumatic Brain Injury With Levetiracetam and Lacosamide Traumatic Brain Injury Recruiting
Phase 3
NCT07412132 Evaluation of the Efficacy, Safety, and Tolerability of Lacosamide in Major Depressive… Bipolar Affective Disorder Recruiting
Phase 1
NCT05603702 STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With… Chronic Pain Active, Not Recruiting
Sponsors Running Lacosamide Trials
Indiana University (1) Wake Forest University Health Sciences (1) University of Sao Paulo (1)
Disease Areas
Bipolar Disorder (1)
Get alerts when Lacosamide trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free